History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure

JACC Heart Fail. 2019 Jan;7(1):47-55. doi: 10.1016/j.jchf.2018.09.008. Epub 2018 Nov 5.

Abstract

Objectives: This study sought to characterize the course of decongestion among patients hospitalized for acute heart failure (AHF) by history of atrial fibrillation (AF) and/or atrial flutter (AFL).

Background: AF/AFL and chronic heart failure (HF) commonly coexist. Little is known regarding the impact of AF/AFL on relief of congestion among patients who develop AHF.

Methods: We pooled patients from 3 randomized trials of AHF conducted within the Heart Failure Network, the DOSE (Diuretic Optimization Strategies) trial, the ROSE (Renal Optimization Strategies) trial, and the CARRESS-HF (Cardiorenal Rescue Study in Acute Decompensated Heart Failure) trial. The association between history of AF/AFL and in-hospital changes in various metrics of congestion was assessed using covariate-adjusted linear and ordinal logistic regression models.

Results: Of 750 unique patients, 418 (56%) had a history of AF/AFL. Left ventricular ejection fraction was higher (35% vs. 27%, respectively; p < 0.001), and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels were nonsignificantly lower at baseline (4,210 pg/ml vs. 5,037 pg/ml, respectively; p = 0.27) in patients with AF/AFL. After adjustment of covariates, history of AF/AFL was associated with less substantial loss of weight (-5.7% vs. -6.5%, respectively; p = 0.02) and decrease in NT-proBNP levels (-18.7% vs. -31.3%, respectively; p = 0.003) by 72 or 96 h. History of AF/AFL was also associated with a blunted increase in global sense of well being at 72 or 96 h (p = 0.04). There was no association between history of AF/AFL and change in orthodema congestion score (p = 0.67) or 60-day composite clinical endpoint (all-cause mortality or any rehospitalization; hazard ratio: 1.21; 95% confidence interval: 0.92 to 1.59; p = 0.17).

Conclusions: More than half of the patients admitted with AHF had a history of AF/AFL. History of AF/AFL was independently associated with a blunted course of in-hospital decongestion. Further research is required to understand the utility of specific therapies targeting AF/AFL during hospitalization for AHF.

Keywords: atrial fibrillation; atrial flutter; body weight; decongestion; heart failure.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acute Disease
  • Aged
  • Aged, 80 and over
  • Atrial Fibrillation / epidemiology*
  • Atrial Flutter / epidemiology*
  • Cardiotonic Agents / therapeutic use
  • Comorbidity
  • Diuretics / therapeutic use*
  • Dopamine / therapeutic use
  • Dyspnea / physiopathology
  • Edema, Cardiac / drug therapy*
  • Edema, Cardiac / epidemiology
  • Edema, Cardiac / metabolism
  • Female
  • Heart Failure / drug therapy*
  • Heart Failure / epidemiology
  • Heart Failure / metabolism
  • Heart Failure / physiopathology
  • Humans
  • Linear Models
  • Logistic Models
  • Male
  • Middle Aged
  • Natriuretic Agents / therapeutic use
  • Natriuretic Peptide, Brain / metabolism
  • Natriuretic Peptide, Brain / therapeutic use
  • Peptide Fragments / metabolism
  • Prognosis
  • Proportional Hazards Models
  • Stroke Volume
  • Treatment Outcome

Substances

  • Cardiotonic Agents
  • Diuretics
  • Natriuretic Agents
  • Peptide Fragments
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain
  • Dopamine